In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression.
Clinically, a decrease in blood pH may be due to either a reduction in bicarbonate concentration ([HCO(-)(3)], metabolic acidosis) or an increase in PCO(2) (respiratory acidosis). In mammals, metabolic acidosis induces a far greater increase in urine calcium excretion than respiratory acidosis. In cultured bone, metabolic acidosis induces a marked increase in calcium efflux and a decrease in osteoblastic collagen synthesis, whereas isohydric respiratory acidosis has little effect on either parameter. We have shown that metabolic acidosis prevents the normal developmental increase in the expression of RNA for matrix Gla protein and osteopontin in chronic cultures of primary murine calvarial bone cells (predominantly osteoblasts) but does not alter expression of osteonectin. To compare the effects of isohydric metabolic and respiratory acidosis on expression of these genes, bone cell cultures were incubated in medium at pH approximately 7.2 to model metabolic ([HCO(-)(3)], approximately 13 mM) or respiratory (PCO(2), approximately 80 mmHg) acidosis or at pH approximately 7.4 as a control. Cells were sampled at weeks 4, 5, and 6 to assess specific RNA content. At all time periods studied, both metabolic and respiratory acidosis inhibited the expression of RNA for matrix Gla protein and osteopontin to a similar extent, whereas there was no change in osteonectin expression. In contrast to the significant difference in the effects of metabolic and respiratory acidosis on bone calcium efflux and osteoblastic collagen synthesis, these two forms of acidosis have a similar effect on osteoblastic RNA expression of both matrix Gla protein and osteopontin. Thus, although several aspects of bone cell function are dependent on the type of acidosis, expression of these two matrix genes appears to be regulated by extracellular pH, independently of the type of acidosis.
Frick
K K
KK
Nephrology Unit, Department of Medicine, University of Rochester School of Medicine, Rochester, New York 14642, USA. Kevin_Frick@URMC.Rochester.edu
Bushinsky
D A
DA
D000138:Acidosis / Q000235:genetics* / Q000378:metabolism; D000142:Acidosis, Respiratory / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D002135:Calcium-Binding Proteins / Q000235:genetics* / Q000378:metabolism; D002478:Cells, Cultured; D016326:Extracellular Matrix Proteins; D015870:Gene Expression; D066298:In Vitro Techniques; D051379:Mice; D008815:Mice, Inbred Strains; D010006:Osteoblasts / Q000378:metabolism / Q000502:physiology*; D015676:Osteonectin / Q000235:genetics / Q000378:metabolism; D053495:Osteopontin; D012313:RNA / Q000378:metabolism; D012795:Sialoglycoproteins / Q000235:genetics* / Q000378:metabolism; D012886:Skull / Q000166:cytology / Q000378:metabolism / Q000502:physiology; D000097568:Matrix Gla Protein
D002135:Calcium-Binding Proteins; D016326:Extracellular Matrix Proteins; D015676:Osteonectin; D053495:Osteopontin; D012313:RNA; D012795:Sialoglycoproteins; D000097568:Matrix Gla Protein; C506896:Spp1 protein, mouse